GHC position paper: COVID-19 vaccination in humanitarian settings

Overview

Access to therapeutics, vaccines, diagnostics and other health products for COVID-19 must be considered as global public goods and thus made equitable, affordable, available, appropriate, safe and of assured quality for all those who need them, leaving no one behind. 

Developed with 28 key partners, agencies and clusters involved in the COVID-19 response, this position paper provides key messages to guide global and country level health cluster partners to advocate and support equitable vaccine availability and uptake for populations of concern in humanitarian settings.